CAMP4 Therapeutics Corp. (CAMP)
4.48
+0.68
(+17.89%)
USD |
NASDAQ |
Sep 03, 16:00
4.42
-0.06
(-1.34%)
After-Hours: 20:00
CAMP4 Therapeutics EPS Diluted (Quarterly) : -0.5788 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5788 |
| March 31, 2026 | -0.3165 |
| December 31, 2025 | -0.7762 |
| September 30, 2025 | -0.5536 |
| June 30, 2025 | -0.6244 |
| March 31, 2025 | -0.6169 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.6592 |
| September 30, 2024 | -0.6688 |
| June 30, 2024 | -0.6448 |
| March 31, 2024 | -0.6176 |
| December 31, 2023 | -0.666 |
| September 30, 2023 | -0.5801 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | -0.0616 |
| Ocugen, Inc. | -0.0734 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.53M |
| Revenue (Quarterly) | 1.779M |
| Total Expenses (Quarterly) | 35.31M |
| Enterprise Value | 112.57M |
| Gross Profit Margin (Quarterly) | 71.89% |
| Profit Margin (Quarterly) | -1.88K% |
| Earnings Yield | -49.67% |
| Normalized Earnings Yield | -32.60 |